Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Eledon Pharmaceuticals, Inc. (ELDN)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
20 Dec 2021
Gros David-Alexandre C
Chief Executive Officer, Director, Officer
Eledon Pharmaceuticals, Inc.
(ELDN)
9,000
+28%
2,000
$4.48
$8,960.00
BUY
17 Aug 2021
Gros David-Alexandre C
Chief Executive Officer, Director, Officer
Eledon Pharmaceuticals, Inc.
(ELDN)
7,000
+133%
4,000
$6.21
$24,840.00
BUY
11 Jun 2021
Little Paul Sean
CHIEF FINANCIAL OFFICER, Officer
Eledon Pharmaceuticals, Inc.
(ELDN)
10,000
+100%
10,000
$8.87
$88,700.00
BUY
9 Jun 2021
Gros David-Alexandre C
Chief Executive Officer, Director, Officer
Eledon Pharmaceuticals, Inc.
(ELDN)
3,000
+100%
3,000
$8.01
$24,030.00
SELL
2 Dec 2020
OrbiMed Israel GP Ltd.
10% Owner
Novus Therapeutics, Inc.
(NVUS)
73,650
-58%
103,200
$21.60
$2,229,120.00
BUY
30 Oct 2020
Logos Global Management LP
10% Owner
Novus Therapeutics, Inc.
(NVUS)
150,000
+111%
79,071
$25.59
$1,996,154.90
SELL
20 May 2019
TURKEL CATHERINE C.
President, Officer
Novus Therapeutics, Inc.
(NVUS)
88,662
-0%
529.833
$35.13
$18,611.70
SELL
20 May 2019
Kuwahara Jon
See Remarks, Officer
Novus Therapeutics, Inc.
(NVUS)
5,974
-4%
293.111
$35.13
$10,296.29
SELL
20 May 2019
FLESHER GREGORY J.
Chief Executive Officer, Director, Officer
Novus Therapeutics, Inc.
(NVUS)
156,918
-0%
813.222
$35.13
$28,566.46
BUY
2 May 2019
OrbiMed Israel GP Ltd.
Director, 10% Owner
Novus Therapeutics, Inc.
(NVUS)
3,183,314
+1%
35,900.223
$55.80
$2,003,232.40
BUY
2 May 2019
Chimovits Erez
Director
Novus Therapeutics, Inc.
(NVUS)
3,183,314
+1%
35,900.223
$55.80
$2,003,232.40
SELL
30 Apr 2019
LIFESCI INDEX PARTNERS LLC
10% Owner
Novus Therapeutics, Inc.
(NVUS)
1,065,867
-0%
11.111
$48.60
$540.00
BUY
11 Sep 2018
TURKEL CATHERINE C.
President, Officer
Novus Therapeutics, Inc.
(NVUS)
78,199
+2%
1,871.111
$86.12
$161,146.70
BUY
5 Sep 2018
TURKEL CATHERINE C.
President, Officer
Novus Therapeutics, Inc.
(NVUS)
805
+5%
44.722
$71.39
$3,192.63
BUY
10 May 2017
FLESHER GREGORY J.
Chief Executive Officer, Director, Officer
Novus Therapeutics, Inc.
(NVUS)
115,856
+0%
363.944
$1,618.38
$589,000.40
BUY
10 May 2017
TURKEL CATHERINE C.
Chief Development Officer, Officer
Novus Therapeutics, Inc.
(NVUS)
24,519
+0%
68.586
$1,618.38
$110,998.89
BUY
10 May 2017
OCAMPO CHRISTINE
See Remarks, Officer
Novus Therapeutics, Inc.
(NVUS)
21,590
+0%
61.79
$1,618.38
$99,999.90
BUY
15 Mar 2016
Buckley Stephen Jr.
Director
Tokai Pharmaceuticals Inc
(TKAI)
11,000
+0%
49.383
$929.88
$45,920.00
Home